Authors
Latest:
Approach Health Disparities From All AnglesApril is National Minority Health Month, highlighting the need for health care and community sectors to come together and improve cancer outcomes for underserved populations.
Latest:
Reanne Booker on Factors to Consider When Discussing Palliative RadiationReanne Booker, MN, NP, highlights factors that make a patient a good candidate for palliative radiation.
Latest:
Care Management Tools Can Mitigate Clinician BurnoutAlthough technology alone can’t solve clinician burnout, it can provide the means for organizations to provide better care while increasing efficiency and alleviating stress.
Latest:
Paula Anastasia on PARP Inhibitor Ineligibility Factors for Women With Ovarian CancerPaula Anastasia, RN, MN, AOCN, highlights circumstances in which patients may not be eligible to receive benefit with a PARP inhibitor.
Latest:
Ruxolitinib Plus Belumosudil Confers a 55% Response Rate in GVHDPatients with GVHD treated with ruxolitinib plus belumosudil experienced an overall response rate of 55%, which may suggest an interaction between inflammatory pathways.
Latest:
Cheryl VerStrate on the Pitfalls of Direct-to-Consumer Genetic TestsCheryl VerStrate, DNP, AGPCNP-BC, OCN, discusses why nurses should be prepared to discuss direct-to-consumer genomic testing with their patients.
Latest:
FDA Approves Companion Diagnostic for Zanidatamab in Biliary Tract CancerThe FDA approved a companion diagnostic to identify patients with biliary tract cancer eligible for treatment with zanidatamab.
Latest:
Aliènne Salleroli on Starting the DEI Conversation in Oncology NursingAliènne Salleroli, MS, BSN, RN, OCN, underscores the importance of open dialogue surrounding diversity, equity, and inclusion in oncology leadership.
Latest:
Oncology Rapid Access Clinics: APPs Improve Outcomes for Acutely Ill PatientsOncology rapid-access clinics should be essential to patient care standards across the oncology continuum.
Latest:
Michelle Mollica on Individualizing Care Plans for Cancer SurvivorsMichelle Mollica, PhD, MPH, RN, OCN, of the National Cancer Institute, discusses how childhood cancer survivors may face different challenges than adult or geriatric patients.
Latest:
Bring A Nuanced Approach to Venous Thromboembolism ManagementUnderstanding various clot characteristics and bleeding risk factors can help providers carefully manage acute venous thromboembolism.
Latest:
Kara Morris and Christine Wylie on Oral Cryotherapy for Chemotherapy-Induced Mucositis in Breast CancerKara Morris, MSN, RN, OCN; and Christine Wylie, MSN, RN, OCN, discuss the benefits of oral cryotherapy for patients receiving dose-dense doxorubicin.
Latest:
Elizabeth Aronson Walks Through the Data Supporting Elranatamab Approval in Multiple MyelomaElizabeth Aronson, MSN, FNP-BCN, OCN, shares what stood out to her about the phase 2 MagnetisMM-3 trial assessing elranatamab in multiple myeloma.
Latest:
Five Researchers Awarded Pilot Project FundingEvery year, Huntsman Cancer Institute receives funding from the American Cancer Society to support the promising research of junior faculty.
Latest:
Rx Road Map: Abemaciclib (Verzenio)Sarah Montini, BSN, RN, OCN, provides an in-depth look at abemaciclib for the treatment of patients with breast cancer in a downloadable reference sheet.
Latest:
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and StagingExperts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.
Latest:
Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing RadiationHilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Onvansertib Combo Appears Efficacious in KRAS+ Metastatic Colorectal CancerThe combination of onvansertib plus FOLFIRI/bevacizumab showed promise among patients with KRAS-mutated metastatic colorectal cancer.
Latest:
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPCThe median overall survival with niraparib, abiraterone acetate, and prednisone was 30.4 months vs 28.6 months with abiraterone acetate and prednisone alone.
Latest:
Melanie Darvish on Receiving an ONS Scholarship and What it Means to Be An Oncology NurseMelanie Darvish, BSN, RN, shares her experience attending the Oncology Nursing Society (ONS) Congress with an ONS Scholarship.
Latest:
Many Patients Are Under-Sedated During End-of-Life Cancer CareDavid Hui, MD, MSc, from The University of Texas MD Anderson Cancer Center, discusses findings indicating that patients with agitated delirium may be under-sedated, in accordance with their personalized sedation goal.
Latest:
Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic CancerKaryn A. Goodman, MD, MS, provides perspective on the potential advantages of stereotactic body radiation therapy in locally advanced pancreatic cancer.
Latest:
A Multidisciplinary Approach Improves a Patient’s Experience With Colon CancerEarly coordination with multiple specialty teams can maximize outcomes and improve quality of life for patients with complex metastatic disease.
Latest:
How I Counsel Patients About Lung Cancer ScreeningA lung cancer screening navigator offers their perspective on shared decision-making.
Latest:
Lung Cancer Survival Improves, But Gaps in Biomarker Testing RemainAccording to the American Lung Association, biomarker testing gaps and low screening rates continue to hinder lung cancer survival; however, rates have improved in the last 5 years regardless.
Latest:
Sherry Adkins Talks Primary Care Provider Communication Following CAR T-cell TherapySherry Adkins, MSN, ANP-C, discusses some key considerations in ensuring quality patient care after they have completed CAR T-cell therapy at a specialized center.
Latest:
Grace Choong and Matthew Goetz On the Impact of Adjuvant Endocrine Therapy Omission in ER+ Positive Breast CancerGrace Choong, MD; and Matthew Goetz, MD, discuss the effect of omitting adjuvant endocrine therapy for patients with estrogen receptor–positive breast cancer who were treated with neoadjuvant chemotherapy.
